Erasca, Inc. (ERAS) vs Iovance Biotherapeutics, Inc. (IOVA)
Erasca, Inc. and Iovance Biotherapeutics, Inc. are both Biotechnology companies. Erasca, Inc. and Iovance Biotherapeutics, Inc. are of similar size ($5.1B and $4.9B). Erasca, Inc. has the higher net margin (0.00% vs −89.1%) and the lower return on invested capital (−203.1% vs −43.0%). Across the 13 metrics below, Iovance Biotherapeutics, Inc. leads on 7 and Erasca, Inc. on 6.
Valuation
Profitability
| Metric | ERAS | IOVA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 48.40% | 65.16% |
| Operating margin | 0.00% | (92.72%) | 0.00% |
| Net margin | 0.00% | (89.09%) | 0.00% |
| Free cash flow margin | 0.00% | (91.21%) | 0.00% |
| Return on equity | (78.25%) | (40.36%) | (57.72%) |
| Return on assets | (65.25%) | (31.76%) | (49.22%) |
| Return on invested capital | (203.13%) | (42.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack